Ferroptosis-Regulated Cell Death as a Therapeutic Strategy for Neurodegenerative Diseases: Current Status and Future Prospects

被引:5
作者
Zhang, Jia-Bao [1 ,2 ]
Jia, Xiuqin [3 ]
Cao, Qi [1 ,2 ]
Chen, Yi-Ting [1 ]
Tong, Jie [4 ]
Lu, Guo-Dong [1 ]
Li, Dong-Jie [4 ]
Han, Ting [1 ]
Zhuang, Chun-Lin [1 ]
Wang, Pei [1 ,2 ]
机构
[1] Second Mil Med Univ, Naval Med Univ, Coll Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China
[2] Second Mil Med Univ, Naval Med Univ, Natl Expt Teaching Demonstrat Ctr Pharm, Shanghai 200433, Peoples R China
[3] Capital Med Univ, Beijing Chao Yang Hosp, Dept Radiol, Beijing 100020, Peoples R China
[4] Tongji Univ, Shanghai Peoples Hosp 10, Dept Pharm, Sch Med, Shanghai 200072, Peoples R China
来源
ACS CHEMICAL NEUROSCIENCE | 2023年 / 14卷 / 17期
基金
中国国家自然科学基金;
关键词
Ferroptosis; neurodegenerative diseases; neuroinflammation; ferroptosis regulatory agents; OXIDATIVE STRESS; HUNTINGTONS-DISEASE; MOUSE MODEL; IRON; PROTECTS; INJURY; INHIBITION; MECHANISM; PATHWAY; LIPROXSTATIN-1;
D O I
10.1021/acschemneuro.3c00406
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ferroptosis is increasingly being recognized as a keyelement inthe pathogenesis of diverse diseases. Recent studies have highlightedthe intricate links between iron metabolism and neurodegenerativedisorders. Emerging evidence suggests that iron homeostasis, oxidativestress, and neuroinflammation all contribute to the regulation ofboth ferroptosis and neuronal health. However, the precise molecularmechanisms underlying the involvement of ferroptosis in the pathologicalprocesses of neurodegeneration and its impact on neuronal dysfunctionremain incompletely understood. In our Review, we provide a comprehensiveanalysis and summary of the potential molecular mechanisms underlyingferroptosis in neurodegenerative diseases, aiming to elucidate thedisease progression of neurodegeneration. Additionally, we discusspotential therapeutic agents that modulate ferroptosis with the goalof identifying novel drug molecules for the treatment of neurodegenerativedisorders.
引用
收藏
页码:2995 / 3012
页数:18
相关论文
共 174 条
  • [1] A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis
    Absinta, Martina
    Maric, Dragan
    Gharagozloo, Marjan
    Garton, Thomas
    Smith, Matthew D.
    Jin, Jing
    Fitzgerald, Kathryn C.
    Song, Anya
    Liu, Poching
    Lin, Jing-Ping
    Wu, Tianxia
    Johnson, Kory R.
    McGavern, Dorian B.
    Schafer, Dorothy P.
    Calabresi, Peter A.
    Reich, Daniel S.
    [J]. NATURE, 2021, 597 (7878) : 709 - 714
  • [2] Cytotoxicity of apigenin toward multiple myeloma cell lines and suppression of iNOS and COX-2 expression in STAT1-transfected HEK293 cells
    Adham, Aveen N.
    Abdelfatah, Sara
    Naqishbandi, Alaadin M.
    Mahmoud, Nuha
    Efferth, Thomas
    [J]. PHYTOMEDICINE, 2021, 80
  • [3] The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models
    Amit, Tamar
    Bar-Am, Orit
    Mechlovich, Danit
    Kupershmidt, Lana
    Youdim, Moussa B. H.
    Weinreb, Orly
    [J]. NEUROPHARMACOLOGY, 2017, 123 : 359 - 367
  • [4] Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation
    Angelova, Plamena R.
    Choil, Minee L.
    Berezhnov, Alexey, V
    Horrocks, Mathew H.
    Hughes, Craig D.
    De, Suman
    Rodrigues, Margarida
    Yapom, Ratsuda
    Little, Daniel
    Dolt, Karamjit S.
    Kunath, Tilo
    Devine, Michael J.
    Gissen, Paul
    Shchepinov, Mikhail S.
    Sylantyev, Sergiy
    Pavlov, Evgeny, V
    Klenerman, David
    Abramov, Andrey Y.
    Gandhi, Sonia
    [J]. CELL DEATH AND DIFFERENTIATION, 2020, 27 (10) : 2781 - 2796
  • [5] Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine/glutamate antiporter in Alzheimer?s disease: Evidence of ferroptosis
    Ashraf, Azhaar
    Jeandriens, Jerome
    Parkes, Harold G.
    So, Po-Wah
    [J]. REDOX BIOLOGY, 2020, 32
  • [6] Obacunone Attenuates Liver Fibrosis with Enhancing Anti-Oxidant Effects of GPx-4 and Inhibition of EMT
    Bai, Yongquan
    Wang, Wenwen
    Wang, Li
    Ma, Lirong
    Zhai, Dongsheng
    Wang, Furong
    Shi, Rui
    Liu, Chaoyang
    Xu, Qing
    Chen, Guo
    Lu, Zifan
    [J]. MOLECULES, 2021, 26 (02):
  • [7] Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease
    Bao, Wen-Dai
    Pang, Pei
    Zhou, Xiao-Ting
    Hu, Fan
    Xiong, Wan
    Chen, Kai
    Wang, Jing
    Wang, Fudi
    Xie, Dong
    Hu, Ya-Zhuo
    Han, Zhi-Tao
    Zhang, Hong-Hong
    Wang, Wang-Xia
    Nelson, Peter T.
    Chen, Jian-Guo
    Lu, Youming
    Man, Heng-Ye
    Liu, Dan
    Zhu, Ling-Qiang
    [J]. CELL DEATH AND DIFFERENTIATION, 2021, 28 (05) : 1548 - 1562
  • [8] Targeting miR-124/Ferroportin signaling ameliorated neuronal cell death through inhibiting apoptosis and ferroptosis in aged intracerebral hemorrhage murine model
    Bao, Wen-Dai
    Zhou, Xiao-Ting
    Zhou, Lan-Ting
    Wang, Fudi
    Yin, Xiaoping
    Lu, Youming
    Zhu, Ling-Qiang
    Liu, Dan
    [J]. AGING CELL, 2020, 19 (11)
  • [9] Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury
    Bao, Zhongyuan
    Liu, Yinlong
    Chen, Binglin
    Miao, Zong
    Tu, Yiming
    Li, Chong
    Chao, Honglu
    Ye, Yangfan
    Xu, Xiupeng
    Sun, Guangchi
    Zhao, Pengzhan
    Liu, Ning
    Liu, Yan
    Wang, Xiaoming
    Lam, Sin Man
    Kagan, Valerian E.
    Bayir, Hulya
    Ji, Jing
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [10] Blood-brain barrier link to human cognitive impairment and Alzheimer's disease
    Barisano, Giuseppe
    Montagne, Axel
    Kisler, Kassandra
    Schneider, Julie A.
    Wardlaw, Joanna M.
    Zlokovic, Berislav V.
    [J]. NATURE CARDIOVASCULAR RESEARCH, 2022, 1 (02): : 108 - 115